JP2024545052A5 - - Google Patents
Info
- Publication number
- JP2024545052A5 JP2024545052A5 JP2024532968A JP2024532968A JP2024545052A5 JP 2024545052 A5 JP2024545052 A5 JP 2024545052A5 JP 2024532968 A JP2024532968 A JP 2024532968A JP 2024532968 A JP2024532968 A JP 2024532968A JP 2024545052 A5 JP2024545052 A5 JP 2024545052A5
- Authority
- JP
- Japan
- Prior art keywords
- represented
- oligonucleotide
- compound
- equation
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163285628P | 2021-12-03 | 2021-12-03 | |
| US202163285786P | 2021-12-03 | 2021-12-03 | |
| US202163285933P | 2021-12-03 | 2021-12-03 | |
| US202163285631P | 2021-12-03 | 2021-12-03 | |
| US63/285,786 | 2021-12-03 | ||
| US63/285,628 | 2021-12-03 | ||
| US63/285,631 | 2021-12-03 | ||
| US63/285,933 | 2021-12-03 | ||
| US202263350206P | 2022-06-08 | 2022-06-08 | |
| US63/350,206 | 2022-06-08 | ||
| US202263398992P | 2022-08-18 | 2022-08-18 | |
| US202263398987P | 2022-08-18 | 2022-08-18 | |
| US63/398,987 | 2022-08-18 | ||
| US63/398,992 | 2022-08-18 | ||
| PCT/US2022/051740 WO2023102242A2 (en) | 2021-12-03 | 2022-12-02 | Splice switcher antisense oligonucleotides with modified backbone chemistries |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545052A JP2024545052A (ja) | 2024-12-05 |
| JP2024545052A5 true JP2024545052A5 (https=) | 2026-01-19 |
Family
ID=86613046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532968A Pending JP2024545052A (ja) | 2021-12-03 | 2022-12-02 | 修飾骨格化学を有するスプライススイッチャーアンチセンスオリゴヌクレオチド |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4441226A2 (https=) |
| JP (1) | JP2024545052A (https=) |
| KR (1) | KR20240129626A9 (https=) |
| CN (1) | CN119522282A (https=) |
| AU (1) | AU2022402929A1 (https=) |
| CA (1) | CA3241870A1 (https=) |
| IL (1) | IL313141A (https=) |
| MX (1) | MX2024006612A (https=) |
| WO (1) | WO2023102242A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023356317A1 (en) * | 2022-10-05 | 2025-05-15 | Trace Neuroscience, Inc. | Unc13a antisense oligonucleotides and uses thereof |
| WO2024178223A1 (en) * | 2023-02-24 | 2024-08-29 | Northwestern University | Antisense oligonucleotides for preventing unc13a misplicing |
| GB202315883D0 (en) * | 2023-10-17 | 2023-11-29 | Univ Oxford Innovation Ltd | Method |
| US12612630B2 (en) | 2024-03-05 | 2026-04-28 | Takeda Pharmaceutical Company Limited | Compositions and methods for splicing modulation of UNC13A |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040063658A1 (en) * | 2002-05-06 | 2004-04-01 | Roberts Christopher Don | Nucleoside derivatives for treating hepatitis C virus infection |
| CA2817256A1 (en) * | 2010-11-12 | 2012-05-18 | The General Hospital Corporation | Polycomb-associated non-coding rnas |
| CA3126918A1 (en) * | 2019-01-14 | 2020-07-23 | President And Fellows Of Harvard College | Methods and compositions for restoring stmn2 levels |
| EP3976010A4 (en) * | 2019-06-03 | 2023-08-02 | Quralis Corporation | Oligonucleotides and methods of use for treating neurological diseases |
-
2022
- 2022-12-02 WO PCT/US2022/051740 patent/WO2023102242A2/en not_active Ceased
- 2022-12-02 CA CA3241870A patent/CA3241870A1/en active Pending
- 2022-12-02 CN CN202280090925.2A patent/CN119522282A/zh active Pending
- 2022-12-02 EP EP22902271.0A patent/EP4441226A2/en active Pending
- 2022-12-02 IL IL313141A patent/IL313141A/en unknown
- 2022-12-02 AU AU2022402929A patent/AU2022402929A1/en active Pending
- 2022-12-02 KR KR1020247021691A patent/KR20240129626A9/ko active Pending
- 2022-12-02 MX MX2024006612A patent/MX2024006612A/es unknown
- 2022-12-02 JP JP2024532968A patent/JP2024545052A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024545052A5 (https=) | ||
| CA2659103C (en) | Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups | |
| JP2024543214A5 (https=) | ||
| US20250388620A1 (en) | Efficient method for making highly purified 5’- capped oligonucleotides | |
| US11142545B2 (en) | Synthesis of thiolated oligonucleotides without a capping step | |
| JP2018501816A5 (https=) | ||
| RU2016118528A (ru) | Лечение заболеваний, связанных с альфа-субъединицей потенциалзависимого натриевого канала (scna), путем ингибирования природного антисмыслового транскрипта гена scna | |
| US11453881B2 (en) | Modified oligonucleotides for use in treatment of tauopathies | |
| RU2012153703A (ru) | Соединения двухцепочечных рнк к rhoa и их применение | |
| JP2024534157A5 (https=) | ||
| US11597926B2 (en) | Thiophosphoramidites | |
| JP2021515784A5 (https=) | ||
| RU2020125769A (ru) | Олигонуклеотиды для модуляции экспрессии tmem106b | |
| US20210292358A1 (en) | Oligonucleotides comprising a phosphorotrithioate internucleoside linkage | |
| JP2023528435A5 (https=) | ||
| JP2024540271A5 (https=) | ||
| US20240294915A1 (en) | Oligonucleotides for Modulating Apolipoprotein E4 Expression | |
| JP2025501682A5 (https=) | ||
| JP2023545041A (ja) | Ｄｍｄ患者におけるエクソン５１スキッピングによるジストロフィンレスキューのためのオリゴマー化合物 | |
| US11898145B2 (en) | Enhanced oligonucleotides for inhibiting RTEL1 expression | |
| JP2022531177A5 (https=) | ||
| JP2024527292A5 (https=) | ||
| WO2024238448A3 (en) | Chimeric capsid recombinant adeno-associated virus with bbb penetration and microglia targeting (aav-bm) | |
| JP2023529457A5 (https=) | ||
| US20230212572A1 (en) | Guanosine Analogues for Use in Therapeutics Polynucleotides |